Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
TD Cowen on Walgreens Boosts Alliance (WBA): 'continued challenges in retail pharmacy'
June 27, 2024 8:51 AM EDTTD Cowen analyst Charles Rhyee reiterated a Buy rating and $35.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "F3Q adj EPS $0.63 missed cons $0.69. WBA narrowed FY24 guide to $2.80-$2.95 (from $3.20-$3.35), which assumes continued challenges in retail pharmacy.... More
RBC Capital on Walgreens (WBA): 'ongoing consumer weakness and pressure on pharmacy margin'
June 27, 2024 8:28 AM EDTRBC Capital analyst Anton Hie reiterated a Sector Perform rating and $22.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "WBA posted fiscal 3Q24 earnings slightly below expectations driven by ongoing consumer weakness and pressure on pharmacy margin, partially offset by another quarter of good International performance and positive EBITDA contribution from U.S. Healthcare. Management lowered its adjusted EPS guidance by $0.40 at the midpoint, or -12%... More
